NO167806C - Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-oksatiolan/kinuklidinforbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-oksatiolan/kinuklidinforbindelser.

Info

Publication number: NO167806C
Authority: NO; Norway
Prior art keywords: hydrogen; compounds; group; sec; oxatatiolan
Prior art date: 1987-10-28

Application number

NO884790A

Other languages

English (en)

Norwegian (no)

Other versions

NO884790L (no

NO167806B (no

NO884790D0 (no

Inventor

Abraham Fisher

Ishai Karton

Original Assignee

Il Rep By Prime Mini Off Israe

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-28

Filing date

1988-10-27

Publication date

1991-12-11

1988-10-27 Application filed by Il Rep By Prime Mini Off Israe filed Critical Il Rep By Prime Mini Off Israe

1988-10-27 Publication of NO884790D0 publication Critical patent/NO884790D0/no

1989-05-02 Publication of NO884790L publication Critical patent/NO884790L/no

1991-09-02 Publication of NO167806B publication Critical patent/NO167806B/no

1991-12-11 Publication of NO167806C publication Critical patent/NO167806C/no

Links

150000001875 compounds Chemical class 0.000 title abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 4
239000001257 hydrogen Substances 0.000 abstract 4
150000002431 hydrogen Chemical class 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000004103 aminoalkyl group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000001713 cholinergic effect Effects 0.000 abstract 1
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
229910052805 deuterium Inorganic materials 0.000 abstract 1
239000000032 diagnostic agent Substances 0.000 abstract 1
229940039227 diagnostic agent Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
229910052722 tritium Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D497/20—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compositions Of Macromolecular Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

NO884790A 1987-10-28 1988-10-27 Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-oksatiolan/kinuklidinforbindelser. NO167806C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11447387A	1987-10-28	1987-10-28
US07/189,210 US4876260A (en)	1987-10-28	1988-05-02	Oxathiolanes

Publications (4)

Publication Number	Publication Date
NO884790D0 NO884790D0 (no)	1988-10-27
NO884790L NO884790L (no)	1989-05-02
NO167806B NO167806B (no)	1991-09-02
NO167806C true NO167806C (no)	1991-12-11

Family

ID=26812231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO884790A NO167806C (no)	1987-10-28	1988-10-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-oksatiolan/kinuklidinforbindelser.

Country Status (13)

Country	Link
US (1)	US4876260A (fr)
EP (1)	EP0314444B1 (fr)
JP (1)	JP2753280B2 (fr)
KR (1)	KR910007979B1 (fr)
AT (1)	ATE138663T1 (fr)
AU (1)	AU608903B2 (fr)
CA (1)	CA1315791C (fr)
DE (1)	DE3855325T2 (fr)
DK (1)	DK175064B1 (fr)
ES (1)	ES2087854T3 (fr)
IL (1)	IL87834A (fr)
NO (1)	NO167806C (fr)
NZ (1)	NZ226415A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5534520A (en) *	1990-04-10	1996-07-09	Fisher; Abraham	Spiro compounds containing five-membered rings
US5852029A (en) *	1990-04-10	1998-12-22	Israel Institute For Biological Research	Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
JP2683783B2 (ja) *	1992-07-10	1997-12-03	雪印乳業株式会社	シェーグレン症候群治療剤
DE4343838C2 (de) *	1993-12-22	1998-07-09	Lohmann Therapie Syst Lts	Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung
US6290986B1 (en)	1996-10-24	2001-09-18	Pharmaceutical Applications Associates, Llc	Method and composition for transdermal administration of pharmacologic agents
US6572880B2 (en)	1996-10-24	2003-06-03	Pharmaceutical Applications Associates Llc	Methods and transdermal compositions for pain relief
US6479074B2 (en)	1996-10-24	2002-11-12	Pharmaceutical Applications Associates Llc	Methods and transdermal compositions for pain relief
WO1998054189A1 (fr)	1997-05-30	1998-12-03	Neurosearch A/S	Derives de spiro-quinuclidine, leur preparation et utilisation
US20040209849A1 (en) *	1998-11-27	2004-10-21	Sanochemia Pharmazeutika Aktiengesellschaft	Use of effectors of the central cholinergic nervous system for treatment of delirium
JP4447685B2 (ja) *	1999-01-14	2010-04-07	第一三共株式会社	皮膚乾燥症治療剤
US6433168B1 (en)	1999-07-26	2002-08-13	Sumika Fine Chemicals Co., Ltd.	Highly pure phenothiazine compound, production method thereof, production method of intermediate therefor, and hydrate and novel crystal as starting materials for the intermediate
EP2320661B8 (fr)	2001-11-29	2015-09-02	Godo Kaisha IP Bridge 1	Procédé de retrait de distorsion de codage
AU2003223093B2 (en) *	2002-05-03	2010-02-04	Israel Institute For Biological Research	Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
CN101472924A (zh) *	2006-06-20	2009-07-01	惠氏公司	Kv1.5钾通道抑制剂
US8143400B2 (en) *	2008-01-10	2012-03-27	Apotex Pharmachem Inc.	Process for the preparation and purification of cis-2-methylspiro(1,3-oxathiolane-5,3′)quiniclidine hydrochloride
MA32929B1 (fr) *	2008-11-23	2012-01-02	Pfizer	Lactames en tant qu'inhibiteurs de bêta-sécrétase
US9034891B2 (en)	2009-01-26	2015-05-19	Israel Institute For Biological Research	Bicyclic heterocyclic spiro compounds
KR20150116466A (ko)	2009-01-26	2015-10-15	이스라엘 인스티튜트 포 바이올로지컬 리서치	이환형 헤테로사이클릭 스피로 화합물
CN101798311A (zh) *	2010-04-07	2010-08-11	天津炜杰凯华科技有限公司	顺式西维美林的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2146962A1 (en) *	1971-07-28	1973-03-09	Yoshitomi Pharmaceutical	Aza-spirodecanones - useful in treating gastric disorders
IL48453A (en) *	1975-11-11	1980-06-30	Purdue Frederick Co	Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them
IL48452A (en) *	1975-11-11	1979-07-25	Purdue Frederick Co	Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them
US4855290A (en) *	1985-05-10	1989-08-08	State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research	Derivatives of quinuclidine
ZA868369B (en) *	1986-01-10	1987-11-25	Israel State	Derivatives of quinuclidine
IL87234A (en) *	1987-08-13	1992-02-16	Israel Inst Biolog Res	Optical isomers of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine,their preparation and pharmaceutical compositions containing them

1988
- 1988-05-02 US US07/189,210 patent/US4876260A/en not_active Expired - Lifetime
- 1988-09-22 IL IL87834A patent/IL87834A/xx active Protection Beyond IP Right Term
- 1988-09-30 NZ NZ226415A patent/NZ226415A/xx unknown
- 1988-10-12 AU AU23671/88A patent/AU608903B2/en not_active Expired
- 1988-10-26 EP EP88310040A patent/EP0314444B1/fr not_active Expired - Lifetime
- 1988-10-26 AT AT88310040T patent/ATE138663T1/de not_active IP Right Cessation
- 1988-10-26 DE DE3855325T patent/DE3855325T2/de not_active Expired - Lifetime
- 1988-10-26 ES ES88310040T patent/ES2087854T3/es not_active Expired - Lifetime
- 1988-10-27 DK DK198805986A patent/DK175064B1/da not_active IP Right Cessation
- 1988-10-27 CA CA000581526A patent/CA1315791C/fr not_active Expired - Lifetime
- 1988-10-27 NO NO884790A patent/NO167806C/no not_active IP Right Cessation
- 1988-10-28 JP JP63271085A patent/JP2753280B2/ja not_active Expired - Lifetime
- 1988-10-28 KR KR1019880014136A patent/KR910007979B1/ko not_active Expired

Also Published As

Publication number	Publication date
IL87834A0 (en)	1989-03-31
JP2753280B2 (ja)	1998-05-18
NO884790L (no)	1989-05-02
EP0314444B1 (fr)	1996-05-29
ES2087854T3 (es)	1996-08-01
NZ226415A (en)	1990-05-28
AU2367188A (en)	1989-05-04
IL87834A (en)	1992-05-25
CA1315791C (fr)	1993-04-06
JPH0262883A (ja)	1990-03-02
ATE138663T1 (de)	1996-06-15
KR910007979B1 (ko)	1991-10-05
KR890006641A (ko)	1989-06-15
DE3855325T2 (de)	1996-10-10
DK598688A (da)	1989-04-29
US4876260A (en)	1989-10-24
NO167806B (no)	1991-09-02
NO884790D0 (no)	1988-10-27
DK598688D0 (da)	1988-10-27
AU608903B2 (en)	1991-04-18
DK175064B1 (da)	2004-05-17
EP0314444A2 (fr)	1989-05-03
DE3855325D1 (de)	1996-07-04
EP0314444A3 (en)	1990-11-07

Legal Events

Date	Code	Title	Description
2008-11-10	MK1K	Patent expired

Publication	Publication Date	Title
NO167806C (no)	1991-12-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-oksatiolan/kinuklidinforbindelser.
CA2066640A1 (fr)	1991-04-15	Composes heterocycliques
NO162518C (no)	1990-01-10	Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 8-klor-1,5-benzothiazepinderivater.
NO179868C (no)	1997-01-02	Analogifremgangsmåte for fremstilling av terapeutisk aktive kondenserte heterocykliske forbindelser
DE69313427D1 (de)	1997-10-02	Hexahydronapththalinesterderivate, ihre Herstellung und ihre therapeutischen Verwendungen
NO166126C (no)	1991-06-05	Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO163568C (no)	1990-06-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO168418C (no)	1992-02-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser
NO174712C (no)	1994-06-22	Analogifremgangsmåte for fremstilling av terapeutisk aktive heterocykliske forbindelser
DK0573318T3 (da)	1999-10-11	4-phenylcarbamoyl-3-isoxazolcarboxylsyreforbindelser, fremgangsmåde til deres fremstilling, farmaceutiske præparater med in
NO169391C (no)	1992-06-17	Analogifremgangsmaate for fremstilling av et terapeutisk aktivt (-)-cis-quinuklidin og syreaddisjonssalter derav
HUT75647A (en)	1997-05-28	Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
ES8305359A1 (es)	1983-04-01	Un procedimiento para la preparacion de benzamitas sustituidas.
HU900127D0 (en)	1990-03-28	Process for preparation of cyclohexane-acetamide-derivatives
NO164901C (no)	1990-11-28	Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetraoxo-3,7-diazabicyclo (3,3,1)-nonanforbindelser.
HUT41781A (en)	1987-05-28	Process for producing new 1-alkyl-ergoline-thio-urea derivatives
JPS5579372A (en)	1980-06-14	Preparation of carbostyril derivative
DE3782235D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
EP0301466A3 (en)	1990-09-12	Uricosuric composition
ES478072A1 (es)	1979-07-01	Un procedimiento de preparacion de 2-metoxi-benzamidas.
HUT51614A (en)	1990-05-28	Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents
NO870631L (no)	1987-08-19	Cykloheksenkarboksylsyre-estere og -amider.